| Literature DB >> 35831757 |
Florian Recker1,2, Nicolas Haverkamp3, Alexander Mustea4, Ulrich Gembruch5, Tobias Raupach6.
Abstract
OBJECTIVE: Clinical reasoning is an essential skill, the foundations of which should be acquired during medical school. Within the format of test-based learning, such examinations can also be used to support the long-term retention of procedural knowledge necessary for clinical reasoning. The aim was to investigate whether repeated exposure to clinical cases in obstetrics and gynecology (OBGYN) with built-in questions leads to higher learning outcome than pure reading cases and what influence the delay between the intervention and the final test has on the retention of the respective content.Entities:
Keywords: Gynecology; Medical education; Obstetrics; Test-enhanced learning
Mesh:
Year: 2022 PMID: 35831757 PMCID: PMC9281379 DOI: 10.1007/s00404-022-06656-4
Source DB: PubMed Journal: Arch Gynecol Obstet ISSN: 0932-0067 Impact factor: 2.493
Key feature case topics and individual key feature elements
| Key feature case | Individual main features |
|---|---|
| Obstetrics I (case 1) | Determination of the gestational age |
| Maternity report | |
| Indication for induction of labour | |
| Induction of labour with medication | |
| Initial examination and admission to the delivery room for delivery | |
| Evaluation of the results of the vaginal palpation | |
| Indication for micro blood examination | |
| Determination of the dilution of a microblood test | |
| Evaluation of Apgar score and umbilical cord blood gas analysis | |
| Assessment of the CTG according to FIGO | |
| Obstetrics II (case 2) | Initial examination on admission to the delivery room |
| Differential diagnoses for bleeding in the third trimester | |
| Bishop points | |
| Assessment of vaginal palpation | |
| Biometry of the fetus | |
| Assessment of the CTG according to FIGO | |
| First measures in case of CTG decelerations | |
| Measures in case of repeated CTG delays | |
| Definition of the criteria for the Apgar score | |
| Evaluation of the Apgar score | |
| Breast carcinoma (case 3) | Imaging procedure for the diagnosis of a breast cancer |
| Differential diagnoses of benign breast tumours | |
| Hereditary risk factors for breast cancer | |
| Clinical signs of breast cancer | |
| Risk lesions/pre-cancerous lesions for breast cancer | |
| Prerequisites for a curative therapeutic approach | |
| Postoperative approach in an R0 situation | |
| Metastases in breast cancer | |
| Important prognostic receptors in breast cancer | |
| Other carcinomas caused by the BRCA mutation | |
| Cervical carcinoma (case 4) | Definition of heavy menstruation |
| Definition of irregular menstruation | |
| Differential diagnoses for atypical menstrual bleeding | |
| Primary prevention of cervical carcinoma | |
| Evaluation of the acetic acid test | |
| Most frequent histological form of cervical carcinoma | |
| Metastasis of cervical carcinoma | |
| Prerequisites for the R0 situation | |
| Therapy of cervical carcinoma | |
| Follow-up care for cervical carcinoma |
Fig. 1Cross-over study design and case vignettes in the weekly clinical block placement
Fig. 2Study cohort and data enrollment
Item characteristics of the SAQs in the pre- and post-test
| Item | Available points | Pre-test | Post-test | ||||
|---|---|---|---|---|---|---|---|
| Mean value ± SD | Discriminatory power | Item difficulty | Mean value ± SD | Discriminatory power | Item difficulty | ||
| Determination of the gestational age | 2 | 1.35 ± 0.56 | 0.273 | 0.67 | 1.36 ± 0.50 | 0.105 | 0.68 |
| Maternity report | 5 | 2.78 ± 1.34 | 0.049 | 0.56 | 3.80 ± 0.95 | 0.198 | 0.76 |
| Indication for induction of labour | 1 | 0.91 ± 0.29 | 0.165 | 0.91 | 0.94 ± 0.14 | 0.089 | 0.98 |
| Induction of labour with medication | 3 | 0.37 ± 0.58 | 0.094 | 0.12 | 0.61 ± 0.75 | 0.142 | 0.20 |
| Initial examination/admission delivery room | 3 | 0.34 ± 0.52 | 0.011 | 0.11 | 0.40 ± 0.62 | 0.357 | 0.13 |
| Evaluation vaginal results vaginal palpation | 2 | 0.74 ± 0.67 | 0.334 | 0.37 | 1.14 ± 0.62 | 0.241 | 0.57 |
| Indication for micro blood examination | 2 | 1.91 ± 0.39 | 0.308 | 0.95 | 2.00 ± 0.01 | n/a | 1.00 |
| Examination of micro blood examination | 1 | 0.20 ± 0.40 | −0.027 | 0.20 | 0.81 ± 0.40 | 0.270 | 0.81 |
| Evaluation of APGAR-score and umbilical cord BGA | 2 | 1.61 ± 0.78 | 0.162 | 0.81 | 1.73 ± 0.59 | 0.308 | 0.86 |
| Assessment of the CTG according to FIGO | 4 | 3.31 ± 1.37 | 0.263 | 0.83 | 3.60 ± 0.95 | −0.116 | 0.90 |
| Definition of heavy menstruation | 1 | 0.53 ± 0.50 | 0.154 | 0.53 | 0.51 ± 0.50 | 0.111 | 0.51 |
| Definition of irregular menstruation | 1 | 0.75 ± 0.44 | 0.262 | 0.75 | 0.71 ± 0.46 | 0.105 | 0.71 |
| Differential diagnoses of atypical bleeding | 2 | 1.41 ± 0.76 | 0.226 | 0.71 | 1.30 ± 0.80 | 0.230 | 0.65 |
| Primary prevention of cervical carcinoma | 2 | 1.49 ± 0.50 | 0.056 | 0.75 | 1.39 ± 0.51 | 0.079 | 0.70 |
| Evaluation of the acetic acid test | 2 | 1.23 ± 0.72 | 0.126 | 0.62 | 1.24 ± 0.48 | 0.176 | 0.62 |
| Most frequent histological form cervical carcinoma* | 1 | 1.00 ± 0.01 | n/a | 1.00 | 0.99 ± 0.10 | −0.035 | 0.99 |
| Metastasis of cervical carcinoma | 1 | 0.85 ± 0.36 | 0.291 | 0.85 | 0.93 ± 0.26 | 0.300 | 0.93 |
| Prerequisites for the R0 situation | 2 | 1.80 ± 0.43 | 0.203 | 0.90 | 1.72 ± 0.50 | 0.054 | 0.86 |
| Therapy of cervical carcinoma | 1 | 0.94 ± 0.23 | 0.271 | 0.94 | 0.98 ± 0.14 | 0.397 | 0.98 |
| Follow-up care for cervical carcinoma | 2 | 1.07 ± 0.82 | −0.030 | 0.54 | 0.91 ± 0.81 | 0.076 | 0.45 |
| Initial examination on admission to the delivery room | 4 | 1.63 ± 0.85 | 0.101 | 0.41 | 1.99 ± 0.98 | 0.239 | 0.50 |
| Differential diagnoses third trimester bleeding | 4 | 2.21 ± 0.73 | 0.136 | 0.55 | 2.44 ± 0.72 | 0.229 | 0.61 |
| Bishop score | 1 | 0.69 ± 0.46 | 0.090 | 0.69 | 0.41 ± 0.50 | 0.123 | 0.41 |
| Assessment of vaginal palpation | 1 | 0.77 ± 0.42 | 0.289 | 0.77 | 0.84 ± 0.37 | 0.352 | 0.84 |
| Biometry of the fetus | 3 | 0.48 ± 0.87 | 0.142 | 0.16 | 0.10 ± 0.50 | 0.090 | 0.03 |
| Assessment of the CTG according to FIGO | 1 | 0.99 ± 0.10 | 0.143 | 0.99 | 0.98 ± 0.14 | 0.006 | 0.98 |
| First measures in case of CTG decelerations | 1 | 0.49 ± 0.50 | 0.058 | 0.49 | 0.40 ± 0.49 | 0.016 | 0.40 |
| Measures in case of repeated CTG delays | 1 | 0.84 ± 0.37 | 0.301 | 0.84 | 0.65 ± 0.48 | 0.163 | 0.65 |
| Definition criteria for the APGAR score | 5 | 4.93 ± 0.53 | 0.493 | 0.99 | 5.00 ± 0.01 | n/a | 1.00 |
| Evaluation of the Apgar score | 1 | 0.82 ± 0.39 | 0.292 | 0.82 | 0.87 ± 0.34 | 0.350 | 0.87 |
| Imaging procedure Breast cancer diagnosis* | 1 | 1.00 ± 0.01 | n/a | 1.00 | 1.00 ± 0.01 | n/a | 1.00 |
| Differential diagnoses benign breast tumours | 4 | 3.61 ± 0.91 | 0.059 | 0.90 | 3.76 ± 0.50 | 0.229 | 0.94 |
| Hereditary risk factors for breast cancer | 2 | 1.62 ± 0.69 | 0.281 | 0.81 | 1.87 ± 0.42 | 0.215 | 0.93 |
| Clinical signs of breast cancer | 3 | 2.26 ± 0.88 | 0.173 | 0.75 | 2.26 ± 0.86 | 0.181 | 0.75 |
| Risk lesions/pre-cancerous lesions Breast cancer | 3 | 2.87 ± 0.39 | 0.098 | 0.96 | 2.88 ± 0.46 | 0.380 | 0.96 |
| Prerequisites for curative therapy approach | 1 | 0.84 ± 0.37 | 0.246 | 0.84 | 0.88 ± 0.33 | 0.101 | 0.88 |
| Postoperative approach in an R0 situation | 1 | 0.79 ± 0.41 | 0.335 | 0.79 | 0.93 ± 0.26 | 0.268 | 0.93 |
| Metastases in breast cancer | 3 | 2.87 ± 0.49 | 0.179 | 0.96 | 2.90 ± 0.42 | 0.269 | 0.97 |
| Prognostic receptor factors in breast cancer | 3 | 2.97 ± 0.23 | 0.217 | 0.99 | 2.95 ± 0.26 | 0.366 | 0.98 |
| Other carcinomas that are caused by BRCA mutation | 1 | 0.99 ± 0.10 | 0.056 | 0.99 | 0.99 ± 0.10 | 0.004 | 0.99 |
Fig. 3Average scores achieved in % in pre-test and post-test. The error bars represent the standard errors. *p = 0.017 in the paired t-test to examine the differences between intervention and control items
Percent scores in intervention and control items in the post-test by time intervals between the intervention and the post-test
| Intervention items | Control items | ||
|---|---|---|---|
| Group 1 | 74.4 ± 9.2 | 72.3 ± 10.2 | 0.274 |
| Group 2 | 74.0 ± 9.8 | 71.4 ± 8.7 | 0.358 |
| Group 3 | 74.0 ± 6.8 | 69.3 ± 8.4 | 0.029 |
| This study is the first to investigate the effectiveness of test-enhanced learning in the field of gynaecology and obstetrics (OBGYN). Repeated testing was more effective than repeated case-based learning in OBGYN. Curricular implementation of longitudinal key feature testing can thus improve learning outcomes for OBGYN. |